KARY ELDRED - 25 Jan 2023 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
25 Jan 2023
Net transactions value
+$1,443
Form type
4
Filing time
26 Jan 2023, 06:44:04 UTC
Previous filing
25 Jan 2022
Next filing
30 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common Stock Purchase $1,443 +1,300 +2.9% $1.11 46,215 25 Jan 2023 Direct
holding GALT Common Stock 2,425 25 Jan 2023 as UTMA custodian for minor child F1
holding GALT Common Stock 2,000 25 Jan 2023 held in trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose.
F2 These shares are held in a special needs trust for which the Reporting Person serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.